The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population

Marije J Hoornweg1, Mark J C Smeulders, Dirk T Ubbink

  • 1Department of Plastic, Reconstructive and Hand Surgery, Academic Medical Centre, Amsterdam, the Netherlands. m.j.hoornweg@amc.uva.nl

Insights

Infantile haemangiomas affect 9.9% of newborns. Key developmental factors include amniocentesis, breech presentation, being first-born, and low birthweight (≤2500g).

Area of Science:

  • Pediatric Oncology
  • Dermatology
  • Epidemiology

Background:

  • Infantile haemangiomas are the most common tumors in infants, yet their causes are unknown.
  • Understanding the etiology of infantile haemangiomas is crucial for insights into their pathogenesis.

Purpose of the Study:

  • To identify etiological determinants and risk factors for infantile haemangioma development.
  • To determine the prevalence of infantile haemangiomas in the general Dutch population.

Main Methods:

  • Cross-sectional screening of 2204 newborns (0-16 months) in the general Dutch population.
  • Case-control design comparing haemangioma cases with controls, collecting pregnancy and infant data.
  • Multivariable logistic regression analysis to identify independent risk factors.

Main Results:

  • The prevalence of infantile haemangiomas was 9.9% (219/2204).
  • Independent risk factors identified: amniocentesis (OR 3.6), breech presentation (OR 2.3), first-born status (OR 1.55), and birthweight ≤2500 g (OR 4.95).
  • No significant difference in pregnancy duration between groups.

Conclusions:

  • The prevalence of infantile haemangiomas is 9.9% in the Dutch population.
  • Four factors—amniocentesis, breech presentation, first-born status, and low birthweight—are significantly associated with infantile haemangioma development.
  • These identified factors may offer critical clues into the pathogenesis of infantile haemangiomas.

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...